T
he National Health Service (NHS) in England provides free healthcare at the point of delivery but it is continuously facing the challenge of significant and enduring financial pressures. Known as the 'Nicholson challenge', the Department of Health demanded that NHS trusts make efficiency savings of up to £20 billion by 2015.
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As a result, primary care trusts (PCTs) began to produce new and revised guidelines on funding for procedures of limited clinical value (PoLCVs). In 2013 PCTs were replaced by clinical commissioning groups (CCGs), which are now responsible for organising the delivery of health services for a set geographical area, allocating their budget independently to commission cost-effective care. Traditionally, the term 'procedure of limited clinical value' has been applied to elective surgical procedures such as complementary therapies, aesthetic treatments or treatments that the National Institute for Health and Care Excellence (NICE) has shown to be not cost-effective. However, as budgets have been reduced, more procedures have been included in this umbrella term, including carpal tunnel decompression, tonsillectomy, grommet surgery, knee arthroscopy, cataract surgery, varicose vein surgery and hysterectomy for menorrhagia.
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The Royal College of Surgeons of England (RCS) has expressed concerns about labelling procedures that are thought to improve patient health and quality of life as 'of limited clinical value' and reducing their availability. 6 As the CCGs have each established local PoLCV guidelines with a paucity of evidence, they demonstrate a wide variability and have started to make the availability of certain procedures a 'postcode lottery' for patients.
2-5,7
One of the procedures labelled as a PoL-CV is surgical decompression of the carpal tunnel. Carpal tunnel syndrome (CTS) is a common condition affecting 5-11% of the population.
8, 9 Bebbington and Furniss have predicted the number of people affected by CTS in the UK will virtually double within the next 15 years.
10
The natural history of CTS is not well understood. There is good evidence that for those with mild symptoms, it may resolve spontaneously (both clinically and neurophysiologically) 11, 12 although in the majority of cases, CTS symptoms will increase in severity over time. Currently, around a third of those diagnosed with CTS undergo surgery 17, 18 and in England 50,632 carpal tunnel decompressions were performed in 2014-2015.
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Although decompression is accepted largely as treatment for more severe symptoms, Bland demonstrated in a survey of more than 4,000 patients that only 75% considered their operation a success after 2 years whereas 8% thought they were worse off. 20 There also remains controversy regarding the appropriate treatment for milder symptoms as well as the timescale over which conservative treatment should be trialled, with both wrist splinting and steroid injection providing at least temporary relief for some patients.
21-24
The disease burden of CTS and the cost to the NHS are clearly significant. The RCS published guidelines for the treatment of CTS, stratifying symptoms into mild, moderate and severe, 25 but these are pending revision.
There is still no national consensus on when it is appropriate to refer patients for specialist opinion after conservative management. The aim of this study was to review the variation in CCG policies between regions.
MeThODs
The policies for the commissioning of carpal tunnel decompression surgery were obtained from each of the CCGs across England in May 2014. These were identified primarily using an online search as a number of policy documents were freely available on the CCG websites. In order to obtain the remaining policies, an individual request was submitted to each CCG under the Freedom of Information Act 2000. Data were collected on the severity and duration of symptoms, any conservative treatment required before carpal tunnel decompression surgery could be funded and whether nerve conduction studies (NCS) were required to confirm diagnosis.
ResULTs
Of the 211 CCGs in England, 175 policies were obtained. Fourteen CCGs did not provide policies and at the time of our request, twenty-two either did not have a policy or were in the process of developing one.
Positive nerve conduction studies
Of the policies obtained, 21 (12%) stated that positive NCS were mandatory before surgery and a further 12 (7%) required this if the diagnosis of CTS was clinically unclear (Figure 1 ). Of these 33 policies, 23 (70%) also specified that patients must have failed conservative treatment by splinting and/or steroid injection for a period of 3 months or longer before referral, with 2 policies giving no timeframe. Two of the policies made no mention of steroid injection. Policies where positive NCS were not necessary prior to referral fell into three categories:
1. Guidelines based on numerical symptom-scoring scales (3 CCGs) 2. Reference to Map of Medicine® guidance (15 CCGs) 3. Locally developed criteria (124 CCGs).
The 124 CCGs that had developed local criteria broadly followed a similar pattern, allowing referral if any of the following conditions were met:
1. Presence of neurological deficit (constant sensory deficit, thenar muscle wasting). 2. Symptoms persisting after a period of conservative treatment with steroid injection and/or nocturnal splinting. 3. Moderate symptoms for a specified time period following a failed period of conservative treatment. 4. Severe symptoms interfering with daily activities (work/self-care/care duties/ sleep). Six policies made no reference to severe symptoms.
Injection optional 75%
Injection mandatory 17%
Injection not mentioned 6%
Two injections mandatory 2% Of the 175 policies, 11 (6%) did not mention steroid injection. Thirty-three (19%) stipulated that at least one injection was mandatory prior to referral, with four of these requiring at least two injections (Figure 2 ).
Duration of conservative treatment
The required duration of conservative treatment with splinting and/or steroid injection ranged considerably between policies. The majority specified 3 months but 48 CCGs did not specify a time period, and the remaining 26 policies required a duration ranging from 2 to 6 months ( Figure 3 ).
DIscUssION
CCG guidance on offering surgery for CTS is highly variable, with some regions implementing referral criteria that are stricter than others. Policies can be divided broadly into two groups: those that require positive NCS before surgery and those that do not. Positive NCS are required by 12% of CCGs before surgery. However, it is well-documented that patients with normal NCS can benefit from surgery and that the sensitivity of NCS is not consistently high. 26 The problem for patients with CTS is that there is no gold standard diagnostic test. As a result, CTS remains an essentially clinical diagnosis in most regions of the UK, 27 unlike in the US, where neurophysiological testing is more freely available. Requesting NCS to confirm clinically obvious CTS increases pressure on this service, leading to longer waiting times for the investigation and delays in subsequent treatment. Within the two groups, there were a number of sub-groups. These consisted of policies that: 1) used scoring symptoms based on the patient's symptoms; 2) referred to Map of Medicine® guidance; and 3) used local criteria. The third sub-group showed reasonable consistency between the criteria used but there was little agreement on what constitutes conservative management and how long this should be trialled prior to referral.
Most policies referred to splinting 'and/ or' steroid injection, with less than 20% requiring at least one injection. In no policy was there an indication of timing of NCS in relation to steroid injection, even though injection is known to alter median nerve motor latency, motor amplitude, sensory velocity and sensory amplitude, and can result in changes in NCS. 28 The length of time before conservative treatment was deemed to have failed varied from eight weeks to six months and many policies gave no indication of an acceptable time period. Fifteen policies directed practitioners to Map of Medicine® guidance, which has two algorithms for referral. The first recommends referral for steroid injection or surgery with severe symptoms, where there is progressive motor or sensory deficit, or where there is no improvement within three months for mild/moderate symptoms. NCS are recommended in cases of uncertain diagnosis or before surgery. The second set of criteria that are quoted were developed by the RCS and differ with respect to recommendation of referral for: persistent symptoms after six weeks of conservative treatment; moderate deteriorating symptoms; and functional impairment. 25 The inclusion of both sets of guidance could result in some variability within a single CCG, let alone across a number of CCGs. Furthermore, a proviso included in the Map of Medicine® care pathway that 'local protocols vary widely' is confusing in the context of local CCGs using this guidance. The result of this variety and lack of clarity among criteria is widespread inconsistency in CCG referral pathways across the country. There is a spectrum of stringency across the policies: in one area of the country patients with moderate symptoms that affect their work would need to have positive NCS, a trial of steroid injection and attempted conservative Clinicians and commissioners must work together to come to an agreement on the referral criteria that provide the best patient care pathway measures for six months whereas elsewhere surgery would be funded without delay on the basis of the symptoms interfering with work.
Currently, there are no national guidelines on CTS management. NICE has produced a clinical knowledge summary (last updated in 2012) that recommends referral for steroid injection or surgery for severe or constant symptoms, progressive motor or sensory deficit, or failure of conservative treatment after three months.
29 NCS are suggested for consideration before surgery or where the diagnosis is uncertain (in agreement with the RCS commissioning guide). 25 The majority of existing CCG policies are not consistent with either of these guidelines. To our knowledge, this is the first study looking at the variation in CCG guidelines for an elective orthopaedic procedure. There have been several other publications on the variability of CCG (or PCT) policies for other elective surgical procedures but these have focused mainly on cosmetic surgery including abdominoplasty, breast augmentation or reduction, post-bariatric body contouring and varicose vein surgery.
2-5 The regional variation in the availability of in vitro fertilisation has also been reported as a 'postcode lottery' . 7 The response rate from CCGs in this study was 83%, which is similar to previous papers (82-86%).
2-4
There remain a number of controversies in the management of CTS, particularly for mild and moderate symptoms, and there is still no national consensus in this area. Those areas that require addressing include:
• specifying the treatments that constitute 'conservative' treatment • the length of time that is acceptable for conservative measures to be employed before they can be deemed to have 'failed' (and defining 'failure') • the role of NCS • the role of steroid injection and surgery in patients with moderate symptoms.
The NHS Right Care programme was developed to explore variation among healthcare provision nationwide and provide commissioners with the opportunity to increase effective healthcare for the population. There is certainly scope for this with respect to management of CTS. Clinicians and commissioners must work together to come to an agreement on the referral criteria that provide the best patient care pathway as well as the best value for the NHS. This is especially important in view of the rising number of operations for CTS in England as it is estimated that these will increase from 66,000 in 2015 to 105,000 in 2030.
cONcLUsION
This study has demonstrated significant variation in CCG guidance for management of CTS across the country. In order to bring about equality for patients and gain the best value for their care, further research should be carried out to obtain national agreement on standards for referral to specialist care.
